Ionis' Tryngolza wins CHMP backing for severe hypertriglyceridemia
EMA's CHMP recommended expanding approval of Ionis Pharmaceuticals' TRYNGOLZA to adults with severe hypertriglyceridemia with fasting triglycerides ≥880 mg/dL. A final European Commission decision is expected in the fourth quarter of 2026, ahead of the previously anticipated timeline. Disclaimer: This news brief was cr